Mural Oncology plc (MURA)
NASDAQ: MURA · Real-Time Price · USD
2.635
-0.135 (-4.87%)
At close: Apr 24, 2025, 4:00 PM
2.570
-0.065 (-2.47%)
After-hours: Apr 24, 2025, 4:20 PM EDT
Mural Oncology Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Mural Oncology stock have an average target of 13, with a low estimate of 6.00 and a high estimate of 18. The average target predicts an increase of 393.36% from the current stock price of 2.64.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 26, 2025.
Analyst Ratings
The average analyst rating for Mural Oncology stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $6 | Strong Buy | Maintains | $18 → $6 | +127.70% | Mar 26, 2025 |
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +583.11% | Mar 12, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +507.21% | Jan 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +583.11% | Nov 14, 2024 |
Financial Forecast
Revenue This Year
49.91M
from 37.15M
Increased by 34.35%
Revenue Next Year
n/a
from 49.91M
EPS This Year
-5.45
from -7.58
EPS Next Year
-2.34
from -5.45
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 42.0M | 5.9M | 43.4M | ||
| Avg | 10.2M | 2.5M | 24.8M | ||
| Low | n/a | n/a | 14.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 13.1% | -41.9% | 1,667.8% | ||
| Avg | -72.5% | -76.0% | 910.4% | ||
| Low | - | - | 477.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.55 | -0.20 | -0.19 | ||
| Avg | -5.45 | -2.34 | -1.96 | ||
| Low | -7.10 | -3.25 | -3.34 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.